» Articles » PMID: 27822311

is the Key Gene Mediator of the Syndromic Obesity Phenotype of Patients with 1p21.3 Microdeletions

Overview
Journal Mol Cytogenet
Publisher Biomed Central
Specialty Biochemistry
Date 2016 Nov 9
PMID 27822311
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Deletions in the long arm of chromosome 1 have been described in patients with a phenotype consisting primarily of obesity, intellectual disability and autism-spectrum disorder. The minimal region of overlap comprises two genes: and .

Case Presentation: We describe a 10-year-old boy with syndromic obesity who carries a novel 1p21.3 deletion overlapping the critical region with the gene only.

Conclusions: This study suggests that is the mediator of the obesity phenotype of patients carrying 1p21.3 microdeletions.

Citing Articles

Generation and transcriptomic characterization of MIR137 knockout miniature pig model for neurodevelopmental disorders.

Xu S, Wang J, Mao K, Jiao D, Li Z, Zhao H Cell Biosci. 2024; 14(1):86.

PMID: 38937838 PMC: 11212353. DOI: 10.1186/s13578-024-01268-8.


RNA epitranscriptomics dysregulation: A major determinant for significantly increased risk of ASD pathogenesis.

Beopoulos A, Gea M, Fasano A, Iris F Front Neurosci. 2023; 17:1101422.

PMID: 36875672 PMC: 9978375. DOI: 10.3389/fnins.2023.1101422.


Understanding autism spectrum disorders with animal models: applications, insights, and perspectives.

Li Z, Zhu Y, Gu L, Cheng Y Zool Res. 2021; 42(6):800-824.

PMID: 34755500 PMC: 8645879. DOI: 10.24272/j.issn.2095-8137.2021.251.


MicroRNAs in the Onset of Schizophrenia.

Thomas K, Zakharenko S Cells. 2021; 10(10).

PMID: 34685659 PMC: 8534348. DOI: 10.3390/cells10102679.


MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy.

Ait-Aissa K, Nguyen Q, Gabani M, Kassan A, Kumar S, Choi S Cardiovasc Diabetol. 2020; 19(1):136.

PMID: 32907629 PMC: 7488343. DOI: 10.1186/s12933-020-01107-3.


References
1.
Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L . Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014; 94(5):677-94. PMC: 4067558. DOI: 10.1016/j.ajhg.2014.03.018. View

2.
Xie H, Sun L, Lodish H . Targeting microRNAs in obesity. Expert Opin Ther Targets. 2009; 13(10):1227-38. PMC: 3197810. DOI: 10.1517/14728220903190707. View

3.
Devanna P, Vernes S . A direct molecular link between the autism candidate gene RORa and the schizophrenia candidate MIR137. Sci Rep. 2014; 4:3994. PMC: 3915307. DOI: 10.1038/srep03994. View

4.
Abu-Elneel K, Liu T, Gazzaniga F, Nishimura Y, Wall D, Geschwind D . Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics. 2008; 9(3):153-61. DOI: 10.1007/s10048-008-0133-5. View

5.
Sher F, Rossler R, Brouwer N, Balasubramaniyan V, Boddeke E, Copray S . Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells. 2008; 26(11):2875-83. DOI: 10.1634/stemcells.2008-0121. View